Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Related structures:
AlphaFold database: Q4QIF1
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 255 | 257 | PF00675 | 0.593 |
CLV_NRD_NRD_1 | 265 | 267 | PF00675 | 0.510 |
CLV_PCSK_KEX2_1 | 255 | 257 | PF00082 | 0.492 |
CLV_PCSK_KEX2_1 | 265 | 267 | PF00082 | 0.652 |
CLV_PCSK_KEX2_1 | 36 | 38 | PF00082 | 0.500 |
CLV_PCSK_PC1ET2_1 | 36 | 38 | PF00082 | 0.500 |
CLV_PCSK_PC7_1 | 261 | 267 | PF00082 | 0.510 |
CLV_PCSK_SKI1_1 | 255 | 259 | PF00082 | 0.510 |
CLV_PCSK_SKI1_1 | 3 | 7 | PF00082 | 0.592 |
CLV_PCSK_SKI1_1 | 52 | 56 | PF00082 | 0.388 |
CLV_PCSK_SKI1_1 | 94 | 98 | PF00082 | 0.372 |
DEG_ODPH_VHL_1 | 64 | 76 | PF01847 | 0.321 |
DOC_MAPK_HePTP_8 | 252 | 264 | PF00069 | 0.477 |
DOC_MAPK_MEF2A_6 | 245 | 252 | PF00069 | 0.487 |
DOC_MAPK_MEF2A_6 | 255 | 264 | PF00069 | 0.445 |
DOC_MAPK_RevD_3 | 242 | 256 | PF00069 | 0.477 |
DOC_PP4_FxxP_1 | 257 | 260 | PF00568 | 0.487 |
DOC_PP4_FxxP_1 | 63 | 66 | PF00568 | 0.318 |
DOC_USP7_MATH_1 | 142 | 146 | PF00917 | 0.397 |
DOC_USP7_MATH_1 | 159 | 163 | PF00917 | 0.397 |
DOC_USP7_MATH_1 | 189 | 193 | PF00917 | 0.535 |
DOC_WW_Pin1_4 | 185 | 190 | PF00397 | 0.418 |
LIG_14-3-3_CanoR_1 | 108 | 112 | PF00244 | 0.299 |
LIG_14-3-3_CanoR_1 | 25 | 29 | PF00244 | 0.346 |
LIG_14-3-3_CanoR_1 | 272 | 276 | PF00244 | 0.540 |
LIG_14-3-3_CanoR_1 | 3 | 9 | PF00244 | 0.487 |
LIG_CSL_BTD_1 | 282 | 285 | PF09270 | 0.536 |
LIG_FHA_1 | 218 | 224 | PF00498 | 0.377 |
LIG_LIR_Apic_2 | 136 | 142 | PF02991 | 0.357 |
LIG_LIR_Apic_2 | 60 | 66 | PF02991 | 0.347 |
LIG_LYPXL_yS_3 | 40 | 43 | PF13949 | 0.522 |
LIG_Pex14_2 | 11 | 15 | PF04695 | 0.431 |
LIG_Rb_LxCxE_1 | 128 | 145 | PF01857 | 0.420 |
LIG_SH2_CRK | 84 | 88 | PF00017 | 0.333 |
LIG_SH2_PTP2 | 139 | 142 | PF00017 | 0.387 |
LIG_SH2_STAT5 | 122 | 125 | PF00017 | 0.286 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.291 |
LIG_SH2_STAT5 | 14 | 17 | PF00017 | 0.431 |
LIG_SH3_1 | 279 | 285 | PF00018 | 0.530 |
LIG_SH3_3 | 279 | 285 | PF00018 | 0.530 |
LIG_TYR_ITIM | 82 | 87 | PF00017 | 0.327 |
MOD_CK1_1 | 24 | 30 | PF00069 | 0.393 |
MOD_GlcNHglycan | 161 | 164 | PF01048 | 0.465 |
MOD_GlcNHglycan | 286 | 289 | PF01048 | 0.593 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.309 |
MOD_GSK3_1 | 185 | 192 | PF00069 | 0.515 |
MOD_GSK3_1 | 284 | 291 | PF00069 | 0.579 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.391 |
MOD_LATS_1 | 92 | 98 | PF00433 | 0.365 |
MOD_N-GLC_1 | 277 | 282 | PF02516 | 0.648 |
MOD_N-GLC_1 | 3 | 8 | PF02516 | 0.574 |
MOD_NEK2_1 | 271 | 276 | PF00069 | 0.580 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.322 |
MOD_PIKK_1 | 55 | 61 | PF00454 | 0.328 |
MOD_PKA_2 | 107 | 113 | PF00069 | 0.300 |
MOD_PKA_2 | 24 | 30 | PF00069 | 0.393 |
MOD_PKA_2 | 271 | 277 | PF00069 | 0.537 |
MOD_Plk_1 | 100 | 106 | PF00069 | 0.412 |
MOD_Plk_1 | 3 | 9 | PF00069 | 0.569 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.321 |
MOD_Plk_4 | 118 | 124 | PF00069 | 0.329 |
MOD_Plk_4 | 24 | 30 | PF00069 | 0.487 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.301 |
MOD_Plk_4 | 94 | 100 | PF00069 | 0.296 |
MOD_ProDKin_1 | 185 | 191 | PF00069 | 0.417 |
TRG_DiLeu_BaEn_2 | 252 | 258 | PF01217 | 0.454 |
TRG_ENDOCYTIC_2 | 14 | 17 | PF00928 | 0.410 |
TRG_ENDOCYTIC_2 | 40 | 43 | PF00928 | 0.478 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.307 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.340 |
TRG_ER_diArg_1 | 255 | 257 | PF00400 | 0.555 |
TRG_ER_diArg_1 | 264 | 266 | PF00400 | 0.463 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0A3 | Leptomonas seymouri | 29% | 96% |
A0A0N1ICC0 | Leptomonas seymouri | 84% | 100% |
A0A0S4JVD5 | Bodo saltans | 27% | 92% |
A0A0S4KEG1 | Bodo saltans | 60% | 83% |
A0A1X0NNY9 | Trypanosomatidae | 61% | 100% |
A0A3S7WQ41 | Leishmania donovani | 98% | 100% |
A0A3S7WRH8 | Leishmania donovani | 29% | 96% |
A4H585 | Leishmania braziliensis | 92% | 100% |
A4H9V5 | Leishmania braziliensis | 28% | 96% |
A4HTG9 | Leishmania infantum | 98% | 100% |
A4HUR5 | Leishmania infantum | 29% | 96% |
B2V5B7 | Clostridium botulinum (strain Alaska E43 / Type E3) | 26% | 100% |
B9K867 | Thermotoga neapolitana (strain ATCC 49049 / DSM 4359 / NBRC 107923 / NS-E) | 26% | 100% |
C9ZPP8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 71% | 100% |
D0A7P7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 97% |
E9AM97 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
E9ANE9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 96% |
Q03YE4 | Leuconostoc mesenteroides subsp. mesenteroides (strain ATCC 8293 / DSM 20343 / BCRC 11652 / CCM 1803 / JCM 6124 / NCDO 523 / NBRC 100496 / NCIMB 8023 / NCTC 12954 / NRRL B-1118 / 37Y) | 26% | 100% |
Q4QH77 | Leishmania major | 26% | 100% |
Q54JC2 | Dictyostelium discoideum | 27% | 100% |
Q94AU7 | Arabidopsis thaliana | 28% | 100% |
Q9C6B3 | Arabidopsis thaliana | 29% | 100% |
Q9FWR5 | Arabidopsis thaliana | 28% | 100% |
V5BBY5 | Trypanosoma cruzi | 27% | 97% |
V5BCJ4 | Trypanosoma cruzi | 71% | 100% |